Abstract
In order to assess β cell secretory capacity after islet transplantation, standardized mixed meal stimulation tests are often used. But these tests are cumbersome and the effect of exogenous insulin on the test results is unclear. The aim of our study was to determine to what extent fasting glycemic indices can estimate stimulated β cell function in islet transplant recipients with and without basal insulin. In total 100 mixed meal stimulation tests, including 31 with concurrent basal insulin treatment, were performed in 36 islet transplant recipients. In a multivariate model, fasting C-peptide and fasting glucose together estimated peak C-peptide with R2 = .87 and area under the curve (AUC) C-peptide with a R2 = .93. There was a larger increase of glucose during tests in which exogenous insulin was used (+7.9 vs +5.3 mmol/L, P < .001) and exogenous insulin use was associated with a slightly lower estimated peak C-peptide (relative change: -15%, P = .02). In islet transplant recipients the combination of fasting C-peptide and glucose can be used to accurately estimate stimulated β cell function after a mixed meal stimulation test, whether exogenous basal insulin is present or not. These data indicate that graft function can b...Continue Reading
References
May 1, 1991·Acta Endocrinologica·H J GjessingO Pedersen
Jun 10, 1998·Annals of Internal Medicine
Dec 5, 1998·Diabetes Care·J C LevyM P Hermans
Apr 30, 2003·Diabetes·Carla J GreenbaumUNKNOWN Immunology of Diabetes Society
Nov 19, 2004·Transplantation·Masafumi GotoOlle Korsgren
Jan 29, 2005·Diabetes Care·Edmond A RyanA M James Shapiro
Nov 22, 2005·Transplantation Proceedings·S MatsumotoK Tanaka
Sep 29, 2006·The New England Journal of Medicine·A M James ShapiroJonathan R T Lakey
Dec 19, 2006·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R N FaradjiR Alejandro
May 10, 2007·The Journal of Clinical Endocrinology and Metabolism·Michael R RickelsAli Naji
Nov 6, 2007·Diabetes Care·Andrea CaumoLorenzo Piemonti
Jan 1, 2008·Cell Transplantation·A S FribergD Brandhorst
Oct 9, 2012·Diabetes, Obesity & Metabolism·J J MeierJ D Veldhuis
Nov 1, 2012·Diabetes Care·Rachel E J BesserJohnny Ludvigsson
May 1, 2013·Diabetes·Michael R RickelsAli Naji
Mar 14, 2014·Diabetes Care·Richard A OramAndrew T Hattersley
Aug 20, 2015·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·M F NijhoffE J P de Koning
Mar 29, 2016·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S ForbesP A Senior
Oct 18, 2016·Diabetic Medicine : a Journal of the British Diabetic Association·S V HopeA G Jones
May 22, 2016·Diabetes Care·Bernhard J HeringUNKNOWN Clinical Islet Transplantation Consortium
Dec 9, 2017·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·Justyna E GołębiewskaPiotr Witkowski
Feb 18, 2018·Transplant International : Official Journal of the European Society for Organ Transplantation·Michael R RickelsSteven White
Sep 1, 2018·Diabetologia·John M WentworthUNKNOWN Immune Tolerance Network Study Group